Effect of multielement intravascular ultrasound on the anticoagulant potency of Enoxaparin

American Journal of Cardiology

Volumn 93, Issue 11, 2004, Pages 1453-1454

  Stouffer, George A ^a   Pathak, Alok ^a   Whinna, Herbert C ^a   Ohman, E Magnus ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ENOXAPARIN; EPTIFIBATIDE;

ADULT; AGED; ANTICOAGULATION; ARTICLE; BLOOD CLOTTING; BLOOD CLOTTING TIME; CASE REPORT; CATHETER; CLINICAL FEATURE; FEMALE; HUMAN; INTRAVASCULAR ULTRASOUND; PRIORITY JOURNAL; THROMBUS;

AGED; ANTICOAGULANTS; ENOXAPARIN; FACTOR XA; FEMALE; HUMANS; MALE; MIDDLE AGED; PEPTIDES; THROMBOSIS; ULTRASONOGRAPHY, INTERVENTIONAL; WHOLE BLOOD COAGULATION TIME;

EID: 2542454762     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2004.02.057     Document Type: Article

References (2)

1. Kereiakes D.J., Grines C., Fry E., Esente P., Hoppensteadt D., Midei M., Barr L., Matthai W., Todd M., Broderick T., et al. Enoxaparin and abciximab adjunctive pharmacotherapy during percutaneous coronary intervention. J Invasive Cardiol. 13:2001;272-278
2. Young J.J., Kereiakes D.J., Grines C.L. Low-molecular-weight heparin therapy in percutaneous coronary intervention the NICE 1 and NICE 4 trials. National Investigators Collaborating on Enoxaparin. J Invasive Cardiol. 12:(suppl E):2000;E14-E18